- Home
- Equipment
- usa massachusetts
- disease lung
Show results for
Refine by
Disease Lung Equipment Supplied In Usa Massachusetts
5 equipment items found
Manufactured by:Third Pole Therapeutics, Inc. based inWaltham, MASSACHUSETTS (USA)
Innovative technology and highly sophisticated engineering that advances the field of inhaled NO by creating a portable and miniaturized platform technology to generate inhaled Nitric Oxide (iNO) on demand, accurately, safely, and reliably and maximize the well-established clinical benefits of iNO through highly differentiated and easy-to-use hospital and mobile devices to treat severe forms of ...
Manufactured by:Emulate based inBoston, MASSACHUSETTS (USA)
Study lung physiology, disease, and the effect of drug candidates. A more human-relevant model for studying pulmonary physiology, with primary human cells in a lung-specific microenvironment. We are currently developing two distinct models of the human lung—the Alveolus Lung-Chip and the Airway ...
by:Vertex Pharmaceuticals based inBoston, MASSACHUSETTS (USA)
Cystic fibrosis (CF) is a rare, chronic and life-shortening genetic disease. It’s a progressive, multi-system disease that affects the lungs, liver, gastrointestinal tract, pancreas, sinuses, sweat glands and reproductive tract. In the lungs, this leads to the buildup of abnormally thick, sticky mucus that can cause chronic ...
Manufactured by:Acorda Therapeutics, Inc. based inPearl River, NEW YORK (USA)
INBRIJA is a prescription medicine used when needed for OFF episodes in adults with Parkinson’s treated with regular carbidopa/levodopa medicine. INBRIJA does not replace regular carbidopa/levodopa ...
Manufactured by:Siemens Healthcare GmbH based inErlangen, GERMANY
The healthcare market is driven by the need to enhance efficiency and efficacy. Delivering on both, minimally invasive image-guided therapies are changing the way healthcare can be provided. And the market is growing: The global population aged 60 and older is projected to reach nearly 2.1 billion by 2050, versus 962 million in 2017.1 This means that the number of patients in all fields will be ...